BeOne Medicines (ONC) Inventory Average (2017 - 2026)
BeOne Medicines (ONC) posted quarterly Inventory Average of $644.9 million for Q1 2026, up 30.33% year-over-year from $494.8 million in Q1 2025, and up 13.15% quarter-over-quarter from $570.0 million in Q4 2025.
BeOne Medicines (ONC) Inventory Average (2017 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Inventory Average for 10 consecutive years, with $644.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 30.33% year-over-year to $644.9 million; the TTM figure through Mar 2026 stood at $644.9 million (up 30.33% YoY), while the FY2025 annual figure was $551.6 million, up 21.08% from the prior year.
- Inventory Average climbed to $644.9 million in Q1 2026 per ONC's latest filing, from $570.0 million in the prior quarter.
- Across five years, Inventory Average topped out at $644.9 million in Q1 2026 and bottomed at $244.1 million in Q1 2022.
- Historically, Inventory Average has averaged $402.9 million across 5 years, with a median of $431.7 million in 2024.
- Annual changes were most pronounced in 2022 — Inventory Average soared 200.9% — and 2025, when it gained 12.01%.
- BeOne Medicines' Inventory Average stood at $286.6 million in 2022, then rose by 27.87% to $366.5 million in 2023, then gained by 26.41% to $463.3 million in 2024, then gained by 23.01% to $570.0 million in 2025, then climbed by 13.15% to $644.9 million in 2026.
- Business Quant data shows ONC's Inventory Average at $644.9 million in Q1 2026, $570.0 million in Q4 2025, and $517.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 707.10 Mn |
| Mar 31, 2026 | 644.91 Mn |
| Dec 31, 2025 | 569.96 Mn |
| Sep 30, 2025 | 517.28 Mn |
| Jun 30, 2025 | 498.76 Mn |
| Mar 31, 2025 | 494.82 Mn |
| Dec 31, 2024 | 463.33 Mn |
| Sep 30, 2024 | 437.47 Mn |
| Jun 30, 2024 | 445.30 Mn |
| Mar 31, 2024 | 431.73 Mn |
| Dec 31, 2023 | 366.53 Mn |
| Sep 30, 2023 | 319.13 Mn |
| Jun 30, 2023 | 309.16 Mn |
| Mar 31, 2023 | 289.67 Mn |
| Dec 31, 2022 | 286.63 Mn |
| Sep 30, 2022 | 276.56 Mn |
| Jun 30, 2022 | 253.92 Mn |
| Mar 31, 2022 | 244.13 Mn |
| Dec 31, 2021 | 196.80 Mn |
| Sep 30, 2021 | 134.28 Mn |